Rj. Tomanek et Tl. Busch, COORDINATED CAPILLARY AND MYOCARDIAL GROWTH IN RESPONSE TO THYROXINE TREATMENT, The Anatomical record, 251(1), 1998, pp. 44-49
Background: Thyroid hormone-induced cardiac hypertrophy is a model of
enhanced physiological growth and angiogenesis. This study addressed t
he growth and geometry of the capillary bed in relation to the develop
ment of cardiac hypertrophy. Methods: Thyroxine was administered daily
(0.2 mg/kg, s.c.) for 5 or 10 days to Fischer 344 rats. After obtaini
ng ventricular function and hemodynamic data, the hearts were perfuse
fixed, and specimens from the left ventricle (LV) were subjected to im
age analysis to determine indices of capillary growth. Results: After
5 days of treatment, prior to cardiac enlargement, capillary length de
nsity was significantly greater in the epimyocardium of the thyroxine
rats than in the controls (saline injected). Most of the increase coul
d be attributed to an increase in capillary numerical density, but som
e enhancement in capillary profile axial ratio suggests that enhanced
tortuosity or formation of oblique channels also occurred. After 10 da
ys of treatment, all capillary parameters (length, volume, and surface
densities) were similar to the controls despite a 30% enlargement of
the LV. We estimate that total LV capillary length increased by 14% du
ring the first 5 days and by 9% during the next 5 days of treatment. C
onclusions: These findings indicate that capillary angiogenesis preced
es the development of ventricular enlargement due to thyroxine adminis
tration. Therefore, angiogenesis in this model is not stimulated by th
e presence of hypertrophy. (C) 1998 Wiley-Liss, Inc.